Antimicrobial Antibodies Are Associated With a Crohn's Disease-Like Phenotype After Ileal Pouch-Anal Anastomosis

Clinical Gastroenterology and Hepatology

Volumn 10, Issue 5, 2012, Pages

  Tyler, Andrea D ^a,b   Milgrom, Raquel ^b   Xu, Wei ^c   Stempak, Joanne M ^b   Steinhart, A Hillary ^b   McLeod, Robin S ^b   Greenberg, Gordon R ^b   Cohen, Zane ^b   Silverberg, Mark S ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Ileal Pouch Anal Anastomosis; Inflammation; Inflammatory Bowel Disease; Pouchitis; Serologic Markers; Surgical Complications; Ulcerative Colitis

Indexed keywords

IMMUNOGLOBULIN G; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY RESPONSE; ANTIMICROBIAL ACTIVITY; ARTICLE; CANADA; CHILD; COLON RESECTION; CROHN DISEASE; FEMALE; HUMAN; ILEITIS; ILEOANAL ANASTOMOSIS; ILEUM POUCH; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; SCHOOL CHILD;

EID: 84859863779     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2011.09.016     Document Type: Article

References (34)

1. Cosnes J., Gower-Rousseau C., Seksik P., et al. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 2011, 140:1785-1794.
2. Allison J., Herrinton L.J., Liu L., et al. Natural history of severe ulcerative colitis in a community-based health plan. Clin Gastroenterol Hepatol 2008, 6:999-1003.
3. Marcello P.W., Roberts P.L., Schoetz D.J., et al. Long-term results of the ileoanal pouch procedure. Arch Surg 1993, 128:500-504.
4. Cohen Z., McLeod R.S., Stern H., et al. The pelvic pouch and ileoanal anastomosis procedure: surgical technique and initial results. Am J Surg 1985, 150:601-607.
5. Simchuk E.J., Thirlby R.C. Risk factors and true incidence of pouchitis in patients after ileal pouch-anal anastomoses. World J Surg 2000, 24:851-856.
6. Dayton M.T., Larsen K.R., Christiansen D.D. Similar functional results and complications after ileal pouch-anal anastomosis in patients with indeterminate vs ulcerative colitis. Arch Surg 2002, 137:690-695.
7. Shen B., Remzi F.H., Brzezinski A., et al. Risk factors for pouch failure in patients with different phenotypes of Crohn's disease of the pouch. Inflamm Bowel Dis 2008, 14:942-948.
8. Shen B., Remzi F.H., Lavery I.C., et al. A proposed classification of ileal pouch disorders and associated complications after restorative proctocolectomy. Clin Gastroenterol Hepatol 2008, 6:145-158. quiz 124.
9. Goldstein N.S., Sanford W.W., Bodzin J.H. Crohn's-like complications in patients with ulcerative colitis after total proctocolectomy and ileal pouch-anal anastomosis. Am J Surg Pathol 1997, 21:1343-1353.
10. Aisenberg J., Wagreich J., Shim J., et al. Perinuclear anti-neutrophil cytoplasmic antibody and refractory pouchitis: a case-control study. Dig Dis Sci 1995, 40:1866-1872.
11. Abdelrazeq A.S., Kandiyil N., Botterill I.D., et al. Predictors for acute and chronic pouchitis following restorative proctocolectomy for ulcerative colitis. Colorectal Dis 2008, 10:805-813.
12. Kartheuser A.H., Dozois R.R., Wiesner R.H., et al. Complications and risk factors after ileal pouch-anal anastomosis for ulcerative colitis associated with primary sclerosing cholangitis. Ann Surg 1993, 217:314-320.
13. Fleshner P., Ippoliti A., Dubinsky M., et al. A prospective multivariate analysis of clinical factors associated with pouchitis after ileal pouch-anal anastomosis. Clin Gastroenterol Hepatol 2007, 5:952-958. quiz 887.
14. Melmed G.Y., Fleshner P.R., Bardakcioglu O., et al. Family history and serology predict Crohn's disease after ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum 2008, 51:100-108.
15. Silverberg M.S., Satsangi J., Ahmad T., et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005, 19(Suppl A):5-36.
16. Landers C.J., Cohavy O., Misra R., et al. Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens. Gastroenterology 2002, 123:689-699.
17. Shen B., Remzi F.H., Nutter B., et al. Association between immune-associated disorders and adverse outcomes of ileal pouch-anal anastomosis. Am J Gastroenterol 2009, 104:655-664.
18. Wasmuth H.H., Trano G., Endreseth B.H., et al. Primary sclerosing cholangitis and extraintestinal manifestations in patients with ulcerative colitis and ileal pouch-anal anastomosis. J Gastrointest Surg 2010, 14:1099-1104.
19. Fleshner P., Ippoliti A., Dubinsky M., et al. Both preoperative perinuclear antineutrophil cytoplasmic antibody and anti-CBir1 expression in ulcerative colitis patients influence pouchitis development after ileal pouch-anal anastomosis. Clin Gastroenterol Hepatol 2008, 6:561-568.
20. White E., Melmed G.Y., Vasiliauskas E.A., et al. A prospective analysis of clinical variables, serologic factors, and outcome of ileal pouch-anal anastomosis in patients with backwash ileitis. Dis Colon Rectum 2010, 53:987-994.
21. Aisenberg J., Legnani P.E., Nilubol N., et al. Are pANCA, ASCA, or cytokine gene polymorphisms associated with pouchitis?. Long-term follow-up in 102 ulcerative colitis patients. Am J Gastroenterol 2004, 99:432-441.
22. Dendrinos K.G., Becker J.M., Stucchi A.F., et al. Anti-Saccharomyces cerevisiae antibodies are associated with the development of postoperative fistulas following ileal pouch-anal anastomosis. J Gastrointest Surg 2006, 10:1060-1064.
23. Devlin S.M., Yang H., Ippoliti A., et al. NOD2 variants and antibody response to microbial antigens in Crohn's disease patients and their unaffected relatives. Gastroenterology 2007, 132:576-586.
24. Papadakis K.A., Yang H., Ippoliti A., et al. Anti-flagellin (CBir1) phenotypic and genetic Crohn's disease associations. Inflamm Bowel Dis 2007, 13:524-530.
25. Sandborn W.J., Landers C.J., Tremaine W.J., et al. Antineutrophil cytoplasmic antibody correlates with chronic pouchitis after ileal pouch-anal anastomosis. Am J Gastroenterol 1995, 90:740-747.
26. Zholudev A., Zurakowski D., Young W., et al. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype. Am J Gastroenterol 2004, 99:2235-2241.
27. Targan S.R. The utility of ANCA and ASCA in inflammatory bowel disease. Inflamm Bowel Dis 1999, 5:61-63. discussion 66-67.
28. Winter H.S., Landers C.J., Winkelstein A., et al. Anti-neutrophil cytoplasmic antibodies in children with ulcerative colitis. J Pediatr 1994, 125:707-711.
29. Waterman M., Xu W., Stempak J.M., et al. Distinct and overlapping genetic loci in Crohn's disease and ulcerative colitis: correlations with pathogenesis. Inflamm Bowel Dis 2011, 17:1936-1942.
30. Fisher S.A., Tremelling M., Anderson C.A., et al. Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease. Nat Genet 2008, 40:710-712.
31. Franke A., Balschun T., Karlsen T.H., et al. Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis. Nat Genet 2008, 40:713-715.
32. Targan S.R., Landers C.J., Yang H., et al. Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease. Gastroenterology 2005, 128:2020-2028.
33. Meier C.B., Hegazi R.A., Aisenberg J., et al. Innate immune receptor genetic polymorphisms in pouchitis: is CARD15 a susceptibility factor?. Inflamm Bowel Dis 2005, 11:965-971.
34. Sehgal R., Berg A., Hegarty J.P., et al. NOD2/CARD15 mutations correlate with severe pouchitis after ileal pouch-anal anastomosis. Dis Colon Rectum 2010, 53:1487-1494.